Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies to carcinoembryonic antigen-related cell adhesion molecule (CEACAM)

Antibodies to carcinoembryonic antigen-related cell adhesion molecule (CEACAM)

US Patent 11891453 · Granted Feb 6, 2024

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Small shedding blocking agents2025
Small shedding blocking agents2025
Methods of use for anti-ILT2 antibodies2025
Methods of use for anti-ILT2 antibodies2025
Methods and compositions for decreasing soluble immune receptor CD282024
Methods and compositions for decreasing soluble immune receptor CD282024
CEACAM1 based point-of-care cancer diagnostic2024
CEACAM based antibacterial agents2024
Antibodies against ILT2 and use thereof2024
Antibodies against ILT2 and use thereof2024
Wearable items providing physiological, environmental and situational parameter 2024
Humanized antibodies against CEACAM12024